跳至主要内容
临床试验/NCT03438240
NCT03438240已完成4 期

Adding Dexmedetomidine Versus Fentanyl to Bupivacaine for Epidural Analgesia in Combination With General Anesthesia for Elective Lumbar Disc Operations: Prospective, Randomized Double-blinded Study

Ain Shams University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年2月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
80
试验地点
1
主要终点
First time to analgesic requirement

研究概览

简要总结

The purpose of this study is to compare addition of dexmedetomidine or fentanyl to bupivacaine for epidural analgesia in combination with general anesthesia in elective lumbar spine operations as regard hemodynamic stability, postoperative pain control and adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Physical status American Society of Anesthesiologist (ASA) I or II.
  • First time elective lumbar dicsectomy or laminectomy

排除标准

  • Patients who refuse to participate
  • Body mass index (BMI) > 30
  • Need an emergency lumbar disc operation
  • ASA physical status > II
  • Major illnesses (e.g. cardiac, respiratory, renal, liver)
  • Coagulation abnormalities
  • Hypovolemia
  • History of increased intracranial pressure
  • Convulsions
  • Spinal stenosis
  • Infection at needle insertion site
  • Other contraindications to epidural procedure
  • Allergy or contraindications to the drugs used in the study
  • History of addiction or alcohol abuse
  • Psychiatric illness or mental retardation

研究组 & 干预措施

Group BF

Active Comparator

Bupivacaine plus Fentanyl

干预措施: Bupivacaine (Drug)

Group BF

Active Comparator

Bupivacaine plus Fentanyl

干预措施: Fentanyl (Drug)

Group BD

Active Comparator

Bupivacaine plus Dexmedetomidine

干预措施: Bupivacaine (Drug)

Group BD

Active Comparator

Bupivacaine plus Dexmedetomidine

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

First time to analgesic requirement

时间窗: First 24 hours postoperatively

After extubation, an intravenous patient-controlled analgesia system, will be connected to the patient (Accufuser Plus® 100 ml, Woo Young Medical Co, Korea) will be prepared with 60 ml normal saline containing 60 mg morphine, it will be programmed to give and 0.5 ml bolus dose with lockout interval of 8 minutes. Time to first Bolus will be estimated considering extubation time is the zero time.

次要结局

  • Total opioid consumption(First 24 hours postoperatively)
  • Visual analogue scale (VAS)(First 24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amin Mohammed Alansary Amin Ahmed Helwa

Assistant Professor

Ain Shams University

研究点 (1)

Loading locations...

相似试验